ANTIVIRAL TREATMENT REDUCES HEPATOCELLULAR CARCINOMA RISK IN NON-CIRRHOTIC, HBEAG-NEGATIVE CHRONIC HEPATITIS B WITH HIGH VIRAL LOAD

被引：0
|
作者：
Choi, Won-Mook [1 ]
Kim, Gi-Ae [2 ]
Choi, Gwang Hyeon [1 ,3 ,4 ]
Choi, Jonggi
Lee, Yun Bin [3 ,4 ]
Sinn, Dong Hyun
Lim, Young-Suk [1 ,5 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea
[2] Kyung Hee Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1137
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [21] THE RISK OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC PATIENTS WITH HEPATITIS B VIRUS INFECTION
    Sarmini, Muhammad Talal
    Pinyopornpanish, Kanokwan
    Mitchell, Brittany
    Fahad, Hamna
    McCullough, Arthur
    GASTROENTEROLOGY, 2020, 158 (06) : S1316 - S1317
  • [22] Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B
    Fung, J.
    Lai, C. -L.
    Seto, W. -K.
    Wong, D. K. -H.
    Yuen, M. -F.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : 738 - 744
  • [23] Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon
    Lampertico, Pietro
    Vigano, Mauro
    Colombo, Massimo
    LIVER INTERNATIONAL, 2011, 31 : 90 - 94
  • [24] Hepatitis B core-related antigen and viral loads status impacts on the risk of hepatocellular carcinoma in patients with HBeAg-negative chronic hepatitis B virus infection
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichirou
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    JOURNAL OF HEPATOLOGY, 2020, 73 : S587 - S587
  • [25] When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?
    Liaw Y.-F.
    Current Hepatology Reports, 2024, 23 (2) : 221 - 226
  • [26] Discontinuation of Nucleos(t)ide Analog treatment in HBeAg-Negative Non-Cirrhotic Chronic Hepatitis B Patients: Real-Life Data of 20 Years
    Mete, Bilgul
    Kaya, Sibel Yildiz
    Kaya, Abdurrahman
    Kurt, Ahmet Furkan
    Bayramlar, Osman Faruk
    Karaali, Ridvan
    Balkan, Ilker Inanc
    Yemisen, Mucahit
    Ozaras, Resat
    Saltoglu, Nese
    Tabak, Fehmi
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (11): : 1163 - 1170
  • [27] DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study
    Papatheodoridis, G.
    Rigopoulou, E.
    Papatheodoridi, M.
    Zachou, K.
    Xourafas, V.
    Gatselis, N.
    Vlachogiannakos, J.
    Dalekos, G.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S26 - S26
  • [28] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
    Jang, Heejoon
    Yoon, Jun Sik
    Park, Soo Young
    Lee, Han Ah
    Jang, Myoung-Jin
    Kim, Seung Up
    Sinn, Dong Hyun
    Seo, Yeon Seok
    Kim, Hwi Young
    Kim, Sung Eun
    Jun, Dae Won
    Yoon, Eileen L.
    Sohn, Joo Hyun
    Ahn, Sang Bong
    Shim, Jae-Jun
    Jeong, Soung Won
    Cho, Yong Kyun
    Kim, Hyoung Su
    Nam, Joon Yeul
    Lee, Yun Bin
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Zoulim, Fabien
    Lampertico, Pietro
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Berg, Thomas
    Buti, Maria
    Calleja, Jose Luis
    Goulis, John
    Manolakopoulos, Spilios
    La Janssen, Harry
    Papatheodoridis, George, V
    Lee, Jeong-Hoon
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : 1343 - +
  • [29] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B
    Jang, Heejoon
    Yoon, Jun Sik
    Park, Soo Young
    Lee, Han Ah
    Jang, Myoung-Jin
    Kim, Seung Up
    Sinn, Dong Hyun
    Seo, Yeon Seok
    Kim, Hwi Young
    Kim, Sung Eun
    Jun, Dae Won
    Yoon, Eileen
    Sohn, Joo Hyun
    Lee, Jun-Hyuk
    Shim, Jae-Jun
    Jeong, Soung Won
    Cho, Yong Kyun
    Kim, Hyoung Su
    Nam, Joon Yeul
    Lee, Yun Bin
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Zoulim, Fabien
    Lampertico, Pietro
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Berg, Thomas
    Buti, Maria
    Luis Calleja, Jose
    Goulis, John
    Manolakopoulos, Spilios
    Janssen, Harry L. A.
    Papatheodoridis, George
    Lee, Jeong-Hoon
    HEPATOLOGY, 2021, 74 : 485A - 486A
  • [30] Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C
    Hayashi, Takeo
    Ogawa, Eiichi
    Furusyo, Norihiro
    Murata, Masayuki
    Hayashi, Jun
    INFECTIOUS AGENTS AND CANCER, 2016, 11
12345